YB2 Stock Overview
An investment holding company, engages in lottery business in the People’s Republic of China and Hong Kong.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Sinopharm Tech Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.014 |
| 52 Week High | HK$0.018 |
| 52 Week Low | HK$0.01 |
| Beta | 1.18 |
| 11 Month Change | -26.09% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 12.40% |
Recent News & Updates
Recent updates
Shareholder Returns
| YB2 | DE Hospitality | DE Market | |
|---|---|---|---|
| 7D | 0% | 5.5% | 0.6% |
| 1Y | n/a | 36.3% | 11.8% |
Return vs Industry: Insufficient data to determine how YB2 performed against the German Hospitality industry.
Return vs Market: Insufficient data to determine how YB2 performed against the German Market.
Price Volatility
| YB2 volatility | |
|---|---|
| YB2 Average Weekly Movement | n/a |
| Hospitality Industry Average Movement | 4.8% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.7% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: YB2's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine YB2's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 19 | n/a | www.sinopharmtech.com.hk |
Sinopharm Tech Holdings Limited, an investment holding company, engages in lottery business in the People’s Republic of China and Hong Kong. It operates through Provision of Lottery-Related Services, Provision of Internet Plus Services, and Manufacturing and Distribution of Personal Protective Equipment segments. The company offers lottery-related hardware and software systems.
Sinopharm Tech Holdings Limited Fundamentals Summary
| YB2 fundamental statistics | |
|---|---|
| Market cap | €3.21m |
| Earnings (TTM) | -€1.28m |
| Revenue (TTM) | €5.16m |
0.6x
P/S Ratio-2.4x
P/E RatioIs YB2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| YB2 income statement (TTM) | |
|---|---|
| Revenue | HK$42.84m |
| Cost of Revenue | HK$37.37m |
| Gross Profit | HK$5.47m |
| Other Expenses | HK$16.11m |
| Earnings | -HK$10.63m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.058 |
| Gross Margin | 12.77% |
| Net Profit Margin | -24.83% |
| Debt/Equity Ratio | 0% |
How did YB2 perform over the long term?
See historical performance and comparison